In early 2026, the AI in Oncology Market is estimated at a valuation of $4.19 billion, propelled by the operationalization of "Multi-Modal Fusion." This year, the industry is buzzing over "Foundation Models for Pathology," which allow AI to synthesize radiology scans, clinical notes, and genomic data into a single, comprehensive "digital twin" of a patient's tumor. This innovation is a primary...